Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
13/09/201721:35GlobeNewswire Inc.Summit Therapeutics Announces Proposed Public Offering of $15.0 Million of American Depositary SharesNASDAQ:SMMTSummit Therapeutics Inc
11/09/201712:10Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
11/09/201712:00GlobeNewswire Inc.Summit Awarded BARDA Contract Worth Up to $62 Million to Support the Development of Ridinilazole for the Treatment of C. diff...NASDAQ:SMMTSummit Therapeutics Inc
05/09/201721:45Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
05/09/201712:00GlobeNewswire Inc.Summit Announces Positive Top-Line Data From an Exploratory Phase 2 Clinical Trial Supporting Ridinilazole as a Highly Select...NASDAQ:SMMTSummit Therapeutics Inc
31/08/201714:24Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
31/08/201712:00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Second Quarter and Half Year Ended 31 July 2017 and Operational Progre...NASDAQ:SMMTSummit Therapeutics Inc
25/08/201714:30GlobeNewswire Inc.Summit Therapeutics to Report Financial Results for the Second Quarter and Half Year Ended 31 July 2017 on 31 August 2017NASDAQ:SMMTSummit Therapeutics Inc
03/08/201712:00GlobeNewswire Inc.Summit Therapeutics to Present at the Canaccord Genuity Growth ConferenceNASDAQ:SMMTSummit Therapeutics Inc
20/07/201712:30Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
18/07/201722:16Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
22/06/201722:44Dow Jones NewsADRs End Higher; Pharmaceuticals Trade ActivelyNASDAQ:SMMTSummit Therapeutics Inc
22/06/201716:21Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
22/06/201712:00GlobeNewswire Inc.Summit Presents Data From Phase 1 Clinical Programme of Ezutromid at the European Paediatric Neurology Society CongressNASDAQ:SMMTSummit Therapeutics Inc
15/06/201712:00GlobeNewswire Inc.Summit Therapeutics to Participate in JMP Securities Life Sciences ConferenceNASDAQ:SMMTSummit Therapeutics Inc
14/06/201721:16Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
14/06/201712:00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2017 and Operational ProgressNASDAQ:SMMTSummit Therapeutics Inc
13/06/201712:00GlobeNewswire Inc.Summit Therapeutics to Report Financial Results for the First Quarter Ended 30 April 2017 on 14 June 2017NASDAQ:SMMTSummit Therapeutics Inc
05/06/201712:00GlobeNewswire Inc.Summit Presents Positive New Preclinical Data on Novel CDI Antibiotic Ridinilazole at ASM Microbe 2017NASDAQ:SMMTSummit Therapeutics Inc
23/05/201712:00GlobeNewswire Inc.Summit Announces Key Appointments to Strengthen Research and Development TeamNASDAQ:SMMTSummit Therapeutics Inc
15/05/201713:38Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
15/05/201712:00GlobeNewswire Inc.Summit Completes Enrolment of PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Patients with DMDNASDAQ:SMMTSummit Therapeutics Inc
28/04/201723:30GlobeNewswire Inc.Phase 2 CoDIFy Trial Results Published in Lancet Infectious Diseases With Data Showing Summit’s Ridinilazole Achieved Stati...NASDAQ:SMMTSummit Therapeutics Inc
27/04/201716:25Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
25/04/201721:12Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
13/04/201722:20Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
30/03/201712:00GlobeNewswire Inc.Summit Therapeutics to Present at the Needham Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
29/03/201721:28Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
29/03/201712:00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2017 and Operational Pr...NASDAQ:SMMTSummit Therapeutics Inc
28/03/201711:11Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT